Panther Life Sciences uses a patented microarray patch (MAP) and software-enabled engineering to deliver shelf-stable skin treatments directly to consumers worldwide. Treatments are loaded onto the MAP patch and applied to the skin to release doses, with shelf-stable formulations allowing global distribution as part of an end-to-end platform. Its MAP technology and platform differentiate it by enabling partnerships across skincare, pharma, biotech, and other industries, not just a single product. The goal is to reshape healthcare by making skin-based treatments easier to access globally and by providing a versatile platform for collaboration and delivery.
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
New York City, New York
Founded
2023
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?